Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET

21 Mar 2016

Abstract excerpt

// Qing-yong Chen 1, * , De-min Jiao 1, * , Jian Wang 1, * , Huizhen Hu 1, * , Xiali Tang 1 , Jun Chen 1 , Hao Mou 1 , Wei Lu 2 1 Department of Respiratory Disease, The 117th Hospital of PLA, Hangzhou, Zhejiang, 310013, P.R. China 2 Department of Oncology, The 117th Hospital of PLA, Hangzhou, Zhejiang, 310013, P.R. China * These authors have contributed equally to this work Correspondence to: Qingyong Chen,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Liver physiology and pathology
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27014910
DOI: 10.18632/oncotarget.8229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting METPMID 27014910Read ↗

Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2Semantic proximity Read ↗

MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.Semantic proximity Read ↗

Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins.Semantic proximity Read ↗

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.Semantic proximity Read ↗

IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated moleculesSemantic proximity Read ↗

MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung CancerSemantic proximity Read ↗

M6A associated TSUC7 inhibition contributed to Erlotinib Resistance in Lung Adenocarcinoma through a Notch Signaling Activation Dependent WaySemantic proximity Read ↗

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.Semantic proximity Read ↗

Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells.Semantic proximity Read ↗

miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP)Semantic proximity Read ↗

Hsa-miR-329 exerts tumor suppressor function through down-regulation of <i>MET</i> in non-small cell lung cancerSemantic proximity Read ↗

MicroRNAs as Regulators of Cisplatin Resistance in Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.